Sign in

CIK 0000849146

  • Accelerated filer
  • Smaller reporting company

Lifevantage Corp

Sign in to watch
Ticker
LFVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
900224471
Phone
+1 801-432-9000
Business address
3300 TRIUMPH BLVD, SUITE 700, LEHI, UT, 84043
Former names
LIFELINE THERAPEUTICS, INC., YAAK RIVER RESOURCES INC
  1. 4 Grant or award Director acquired 17,185 shares (grant or award)
  2. 4 Shares withheld for taxes President and CEO gave up 10,477 shares (to pay taxes)
  3. 4 Grant or award Director acquired 17,185 shares (grant or award)
  4. 4 Grant or award Director acquired 17,185 shares (grant or award)
  5. 4 Open-market buy Director bought 18,824 shares at an average $4.74 ($89,166)
  6. 4 Grant or award President and CEO acquired 276,928 shares (grant or award)
  7. 4 Shares withheld for taxes Chief Marketing Officer gave up 1,863 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Sales Officer gave up 1,546 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 13,011 shares (to pay taxes)
  10. 4 Shares withheld for taxes General Counsel gave up 1,621 shares (to pay taxes)
  11. 4 Exercise or conversion Chief Financial Officer acquired 2,401 shares (option exercise)
  12. 4 Open-market buy Director bought 4,124 shares at $6.94 ($28,632)
  13. 4 Open-market buy Director bought 1,000 shares at $7.63 ($7,632)
  14. 4 Grant or award President and CEO acquired 151,196 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 24,655 shares (grant or award)
  16. 4 Grant or award Chief Marketing Officer acquired 31,558 shares (grant or award)
  17. 4 Grant or award Chief Sales Officer acquired 29,586 shares (grant or award)
  18. 4 Grant or award General Counsel acquired 24,162 shares (grant or award)
  19. 4 Open-market buy Dayton Judd bought 16,504 shares at an average $4.85 ($80,072)
  20. 4/A Derivatives Options or other derivatives

Page 8 of 34 · 673 filings